MARIMED INC.·4

Jun 16, 4:09 PM ET

Crandall Ryan 4

4 · MARIMED INC. · Filed Jun 16, 2026

Research Summary

AI-generated summary of this filing

Updated

Marimed (MRMD) CCO Ryan Crandall Receives RSUs; Shares Withheld

What Happened
Ryan Crandall, Chief Commercial Officer of Marimed Inc. (MRMD), had 250,000 restricted stock units (RSUs) convert into common shares on June 15, 2026. The conversion is reported as an exercise/conversion of a derivative (code M) at $0.00 exercise price. The company withheld 86,626 shares to satisfy tax withholding obligations (code F) at $0.07 per share, reported as $5,977, leaving Crandall with a net 163,374 shares from this vesting event. This was not an open-market purchase or a sale — it reflects RSU vesting and routine tax withholding.

Key Details

  • Transaction date(s): June 15, 2026; Form filed June 16, 2026 (appears timely).
  • Conversion/exercise: 250,000 RSUs → 250,000 shares (exercise price reported $0.00).
  • Withholding: 86,626 shares withheld at $0.07 per share for taxes, totaling $5,977 (disposed, code F).
  • Net shares received: 163,374 (250,000 − 86,626).
  • Shares owned after transaction: not specified in the provided excerpt of the filing.
  • Footnotes: F1 notes RSUs convert one-for-one to common stock; F2 confirms shares withheld satisfy tax withholding; F3 states the RSU grant was on Dec 15, 2025 and remaining RSUs vest in three installments (Dec 15, 2026; Jun 15, 2027; Dec 15, 2027).
  • Transaction codes explained: M = exercise/conversion of derivative (here, RSU conversion), F = shares withheld for taxes.

Context
This was a routine RSU vesting and tax-withholding transaction, not a market buy or sale. Withholding of shares to cover taxes is common and does not by itself indicate insider buying or selling intent. Remaining RSUs from the December 2025 grant will vest on the dates noted in footnote F3.

Insider Transaction Report

Form 4
Period: 2026-06-15
Crandall Ryan
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common stock

    [F1]
    2026-06-15+250,0001,189,429 total
  • Tax Payment

    Common stock

    [F2]
    2026-06-15$0.07/sh86,626$5,9771,102,803 total
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    [F1][F3]
    2026-06-15250,000750,000 total
    Common Stock, par value $.001 per share (250,000 underlying)
Footnotes (3)
  • [F1]RSUs convert to shares of common stock on a one-for-one basis.
  • [F2]Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
  • [F3]The RSUs were granted on December 15, 2025; the remaining RSUs under this grant will vest in three equal installments on each of December 15, 2026, June 15, 2027 and December 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Signature
/s/ Ryan Crandall|2026-06-16

Documents

1 file
  • 4
    wk-form4_1781640580.xmlPrimary

    FORM 4